Compare Stocks: IRMD, PLSE, and APYX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$3.08 +1.0%	$3.83	$1.70 ▼ $5.08	$129.74M	1.32	143,751 shs	25,959 shs
IRMD iRadimed	$86.17 -0.2%	$92.73	$67.84 ▼ $107.90	$1.10B	0.9	108,100 shs	96,025 shs
PLSE Pulse Biosciences	$52.68 +1.1%	$36.39	$12.56 ▼ $54.39	$3.65B	1.62	358,470 shs	977,767 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-1.93%	-25.61%	-19.53%	+53.27%
IRMD iRadimed	0.00%	-1.70%	-4.93%	-5.20%	+19.24%
PLSE Pulse Biosciences	+3.50%	+6.31%	+48.28%	+108.44%	+235.20%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$3.08 +1.0%	$3.83	$1.70 ▼ $5.08	$129.74M	1.32	143,751 shs	25,959 shs
IRMD iRadimed	$86.17 -0.2%	$92.73	$67.84 ▼ $107.90	$1.10B	0.9	108,100 shs	96,025 shs
PLSE Pulse Biosciences	$52.68 +1.1%	$36.39	$12.56 ▼ $54.39	$3.65B	1.62	358,470 shs	977,767 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-1.93%	-25.61%	-19.53%	+53.27%
IRMD iRadimed	0.00%	-1.70%	-4.93%	-5.20%	+19.24%
PLSE Pulse Biosciences	+3.50%	+6.31%	+48.28%	+108.44%	+235.20%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.71	Moderate Buy	$6.60	114.29% Upside
IRMD iRadimed	2.80	Moderate Buy	$120.00	39.26% Upside
PLSE Pulse Biosciences	2.60	Moderate Buy	$45.25	-14.10% Downside

Current Analyst Ratings Breakdown

Latest IRMD, PLSE, and APYX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	PLSE Pulse Biosciences	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$58.00
8/10/2026	PLSE Pulse Biosciences	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$45.00
8/10/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $43.00
8/3/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
7/28/2026	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
7/28/2026	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$35.00
7/17/2026	PLSE Pulse Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/14/2026	APYX Apyx Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/13/2026	APYX Apyx Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
6/24/2026	APYX Apyx Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/4/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$32.00

(Data available from 9/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$58.42M	2.22	N/A	N/A	$0.26 per share	11.85
IRMD iRadimed	$86.34M	12.76	$1.85 per share	46.47	$7.96 per share	10.83
PLSE Pulse Biosciences	$350K	10,417.09	N/A	N/A	$1.44 per share	36.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$11.21M	-$0.20	N/A	N/A	N/A	-14.78%	-76.60%	-13.91%	11/5/2026 (Estimated)
IRMD iRadimed	$22.48M	$1.79	48.14	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/4/2026 (Estimated)

Latest IRMD, PLSE, and APYX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	APYX Apyx Medical	-$0.0820	-$0.07	+$0.0120	-$0.07	$13.18 million	$13.88 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.80	0.93%	N/A	44.69%	1 Years
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Latest IRMD, PLSE, and APYX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.92%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.19	5.68	4.53
IRMD iRadimed	N/A	9.46	8.13
PLSE Pulse Biosciences	N/A	9.63	9.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
IRMD iRadimed	92.34%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.90%
IRMD iRadimed	34.60%
PLSE Pulse Biosciences	74.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	42.12 million	35.43 million	Optionable
IRMD iRadimed	110	12.79 million	8.36 million	Optionable
PLSE Pulse Biosciences	140	69.21 million	18.00 million	Optionable

IRMD, PLSE, and APYX Headlines

Recent News About These Companies

BlackRock Inc. Takes $40.67 Million Position in Pulse Biosciences, Inc $PLSE

September 2 at 3:28 AM | marketbeat.com

Deutsche Bank AG Takes Position in Pulse Biosciences, Inc $PLSE

September 2 at 3:28 AM | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Trading 5.1% Higher on Insider Buying Activity

September 2 at 1:21 AM | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month High - Still a Buy?

September 1 at 10:59 AM | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.1% Following Insider Buying Activity

August 31 at 2:39 PM | marketbeat.com

Liane Rae Teplitsky Purchases 1,036 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock

August 29, 2026 | insidertrades.com

Wall Street Zen Upgrades Pulse Biosciences (NASDAQ:PLSE) to Hold

August 29, 2026 | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded by Wall Street Zen to "Hold" Rating

August 29, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) COO Liane Rae Teplitsky Buys 1,036 Shares

August 28, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) COO Liane Rae Teplitsky Purchases 1,034 Shares

August 28, 2026 | marketbeat.com

Formula Growth Ltd. Invests $832,000 in Pulse Biosciences, Inc $PLSE

August 28, 2026 | marketbeat.com

98,054 Shares in Pulse Biosciences, Inc $PLSE Bought by Panoramic Capital LLC

August 27, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year High - Still a Buy?

August 25, 2026 | marketbeat.com

Pulse Biosciences, Inc (NASDAQ:PLSE) Given Consensus Rating of "Moderate Buy" by Brokerages

August 22, 2026 | americanbankingnews.com

Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE

August 20, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year High - Here's Why

August 19, 2026 | marketbeat.com

Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages

August 17, 2026 | marketbeat.com

Needham & Company LLC Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE)

August 17, 2026 | marketbeat.com

Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns

August 16, 2026 | uk.finance.yahoo.com

Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform

August 16, 2026 | marketbeat.com

Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript

August 13, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, PLSE, and APYX Company Descriptions

Apyx Medical NASDAQ:APYX

$3.08 +0.03 (+0.98%)

Closing price 04:00 PM Eastern

Extended Trading

$3.08 +0.00 (+0.06%)

As of 07:56 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

iRadimed NASDAQ:IRMD

$86.17 -0.21 (-0.24%)

Closing price 04:00 PM Eastern

Extended Trading

$86.11 -0.06 (-0.07%)

As of 07:30 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Pulse Biosciences NASDAQ:PLSE

$52.68 +0.59 (+1.13%)

Closing price 04:00 PM Eastern

Extended Trading

$53.62 +0.94 (+1.79%)

As of 07:55 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IRMD, PLSE, and APYX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IRMD, PLSE, and APYX Earnings

Compare Dividends

Latest IRMD, PLSE, and APYX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IRMD, PLSE, and APYX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, PLSE, and APYX Company Descriptions

Apyx Medical NASDAQ:APYX

iRadimed NASDAQ:IRMD

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IRMD, PLSE, and APYX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IRMD, PLSE, and APYX Earnings

Compare Dividends

Latest IRMD, PLSE, and APYX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IRMD, PLSE, and APYX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, PLSE, and APYX Company Descriptions

Apyx Medical NASDAQ:APYX

iRadimed NASDAQ:IRMD

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools